Rev Urol. 2005 Winter;7(1):1-10.

Validity of the "bother score" in the evaluation and treatment of symptomatic benign prostatic hyperplasia.

Abstract

Benign prostatic hyperplasia (BPH) is a condition that is common among older men. It causes a variety of clinically significant lower urinary tract signs and symptoms. BPH is rarely life-threatening; the decision to seek treatment is frequently based on the degree to which patients find the symptoms bothersome and disruptive of daily activities. Recently developed reliable and valid outcome measures to evaluate treatments for BPH are clinical tools that urologists can use to determine the extent of bother and make treatment decisions. A single question used to determine the "bother score" provides a widely used and statistically valid measure of the need for treatment of BPH. Validation data support the argument that the bother score is a statistically reliable measure of treatment outcome in patients with BPH who view their symptoms as bothersome.

PMID:: 16985801; [PubMed]
PMCID:: PMC1477553

Free PMC Article

Images from this publication.See all images (3) Free text

LinkOut - more resources

Full Text Sources

PubMed Central

Supplemental Content

Save items

Related citations in PubMed

Effect of tamsulosin hydrochloride on lower urinary tract symptoms and quality of life in patients with benign prostatic hyperplasia. Evaluation using bother score. [Drugs Today (Barc). 2007]
Effect of tamsulosin hydrochloride on lower urinary tract symptoms and quality of life in patients with benign prostatic hyperplasia. Evaluation using bother score.
Yoshida M, Sugiyama Y, Masunaga K, Maeda Y, Satoji Y, Nagata T, Inadome A. Drugs Today (Barc). 2007 Jun; 43 Suppl B:1-7.
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. [BJU Int. 2009]
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Rosen RC, Fitzpatrick JM, ALF-LIFE Study Group. BJU Int. 2009 Oct; 104(7):974-83. Epub 2009 May 7.
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH. [BJU Int. 2005]
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
Nickel JC, Elhilali M, Vallancien G, ALF-ONE Study Group. BJU Int. 2005 Mar; 95(4):571-4.
Review Comprehensive patient evaluation for benign prostatic hyperplasia. [Urology. 1998]
Review Comprehensive patient evaluation for benign prostatic hyperplasia.
Jepsen JV, Bruskewitz RC. Urology. 1998 Apr; 51(4A Suppl):13-8.
Review Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia. [Am J Geriatr Pharmacother. 2005]
Review Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.
Logan YT, Belgeri MT. Am J Geriatr Pharmacother. 2005 Jun; 3(2):103-14.

See reviews... See all...

Cited by 1 PubMed Central article

Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia. [Urology. 2007]
Physiologic reactivity to a laboratory stress task among men with benign prostatic hyperplasia.
Ullrich PM, Lutgendorf SK, Kreder KJ. Urology. 2007 Sep; 70(3):487-91; discussion 491-2.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Validity of the "bother score" in the evaluation and treatment of symptomatic be...
Validity of the "bother score" in the evaluation and treatment of symptomatic benign prostatic hyperplasia.
Rev Urol. 2005 Winter ;7(1):1-10.

PubMed
Selecting treatment for high-risk, localized prostate cancer: the case for radic...
Selecting treatment for high-risk, localized prostate cancer: the case for radical prostatectomy.
Rev Urol. 2002 Summer ;4(3):147-52.

PubMed
Selecting treatment for high-risk, localized prostate cancer: the case for radia...
Selecting treatment for high-risk, localized prostate cancer: the case for radiation therapy.
Rev Urol. 2002 Summer ;4(3):141-6.

PubMed
Molecular cloning of mast cell growth factor, a hematopoietin that is active in ...
Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms.
Cell. 1990 Oct 5 ;63(1):235-43.

PubMed
Anemia in men with advanced prostate cancer: incidence, etiology, and treatment.
Anemia in men with advanced prostate cancer: incidence, etiology, and treatment.
Rev Urol. 2004 Winter ;6(1):1-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Validity of the "bother score" in the evaluation and treatment of symptomatic benign prostatic hyperplasia.

Abstract

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information